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ABSTRACT   18 
The atypical two-component system (TCS) AbrC1/2/3 (encoded respectively by 19 
SCO4598/4597/4596), comprising two histidine kinases (HKs) and a response regulator 20 
(RR), is crucial for antibiotic production in Streptomyces coelicolor and for 21 
morphological differentiation under certain nutritional conditions. In this study we 22 
demonstrate that deletion of the RR-encoding gene abrC3, SCO4596, results in a 23 
dramatic decrease in ACT and RED production and delays morphological development. 24 
In contrast, the over-expression of abrC3 in the parent strain leads to a 33% increase in 25 
ACT production in liquid medium. Transcriptomic and ChIP-chip analyses of ∆abrC3 26 
and the parent strain revealed that AbrC3 directly controls ACT production by binding 27 
to the actII-ORF4 promoter region; this was independently verified by in vitro DNA-28 
binding assays. This binding is dependent on the sequence (5’-GAASGSGRMS-3’). In 29 
contrast, the regulation of RED production is not due to direct binding of AbrC3, either 30 
to the redZ or to the redD promoters regions. This study also revealed other members of 31 
the AbrC3 regulon: AbrC3 is a positive autoregulator, which also binds to the promoter 32 
regions of SCO0736, bdtA (SCO3328), absR1 (SCO6992), and SCO6809. The direct 33 
targets share the ten-base consensus binding sequence and may be responsible for some 34 
of the phenotypes of the ∆abrC3 mutant. The identification of the AbrC3 regulon as 35 
part of the complex regulatory network governing antibiotic production widens our 36 
knowledge regarding TCS involvement in control of antibiotic synthesis and may 37 
contribute to the rational design of new hyper-producer host strains through genetic 38 
manipulation of such systems. 39 
 40 
41 
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INTRODUCTION  42 
Antibiotic production in Streptomyces is a complex process controlled by multiple 43 
factors through intricate genetic networks (1-4). This organism inhabits the soil where 44 
the environmental conditions are extremely variable and it must therefore compete with 45 
other organisms for scarce nutrients. Secretion of antibiotics provides a selective 46 
advantage to survive in this adverse environment (5) where it is important to respond 47 
quickly to different stimuli. 48 
TCSs are perhaps the most important signal transduction mechanism in bacteria (Mist-49 
web: http://mistdb.com/; P2CS-web: 50 
http://www.p2cs.org/index.php?PHPSESSID=4c2f13770410fa0fab046d10e6cf90d1) (6, 51 
7). Their relative abundance in a genome reflects an organism’s ability to adapt to 52 
different conditions, being less abundant for example in pathogens such as Chlamydia 53 
and Rickettsia than in free-living organisms such as Streptomyces or Myxococcus where 54 
more than 60 TCSs are present in their respective genomes (8-10). The only bacterial 55 
species lacking TCSs are intracellular pathogens (e.g. Mycoplasma species) and 56 
endosymbionts (e.g. Amoebophilus species) with severely reduced genomes (11). 57 
The Streptomyces AbrC1/2/3 gene cluster (SCO4598/97/96) constitutes an atypical TCS 58 
in that it consists of two histidine kinases (AbrC1 and AbrC2 HKs) of group II and one 59 
response regulator (AbrC3 RR) belonging to NarL group of the HTH LuxR family 60 
regulators (12). It is conserved across all Streptomyces species sequenced to date and is 61 
found to be critical for antibiotic production and morphological differentiation under 62 
certain culture conditions in S. coelicolor (13). Both kinases of the system (AbrC1 and 63 
AbrC2) share high similarity in their kinase domains (85%) although AbrC1 lacks an 64 
internal domain of 50 amino acid residues of AbrC2. Independent promoters control 65 
these three genes, even though the genes for HKs and cognate RRs of TCSs are usually 66 
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arranged in operons (14); these features are conserved in all sequenced Streptomyces 67 
species, suggesting the importance for regulation of these genes. The RR, AbrC3, has 68 
orthologues in more than 20 Streptomyces species sequenced, sharing more than 90% 69 
amino acid identity among them. The deletion of these three genes correlates with 70 
delayed morphological differentiation and a marked reduction in the production of the 71 
antibiotics in S. coelicolor M145: actinorhodin (ACT), undecylprodiginine (RED) and 72 
the calcium-dependent antibiotic (CDA) (13).  73 
In this work we present a detailed genetic, physiological and biochemical 74 
characterization of this important regulatory system. We show that deletion of abrC3 75 
alone leads to a dramatic reduction in ACT and RED production and morphological 76 
development in S. coelicolor. Moreover, overexpression of the AbrC3 regulator yields 77 
to high ACT production both in S. coelicolor and S. lividans. To better characterize the 78 
pleiotropic effects exhibited by ∆abrC3, we conducted a global transcriptome analysis 79 
comparing the ∆abrC3 and the parental strain and show that the low production of ACT 80 
observed in the abrC3 mutant is due to a general down-regulation of transcription of the 81 
act gene cluster. Other regulatory genes previously associated with antibiotic 82 
production, such as sihf (SCO1480) (15, 16), afsS (SCO4425) (17, 18) and absR1 83 
(SCO6992) (19), and with morphological development, for example, wblE (SCO5240) 84 
(20, 21) and bdtA (SCO3328) (22, 23) are also down-regulated in this mutant. 85 
Furthermore, through ChIP-chip analyses, we demonstrate a direct regulation of act 86 
gene expression through AbrC3 and provide independent verification with in vitro 87 
DNA-binding studies. This genome-wide study also revealed additional direct DNA 88 
targets of AbrC3. All of these targets share a common 10 bp sequence (5’-89 
GAASGSGRMS-3’) (S: G or C; R: A or G; M: A or C) and we have shown, by 90 
mutagenesis, that it is indispensable for the binding of AbrC3 to the actII-ORF4 91 
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promoter region. Therefore this sequence defines the putative consensus AbrC3 binding 92 
site. 93 
 94 
MATERIALS AND METHODS 95 
Strains, media and culture conditions 96 
Escherichia coli strain BW25113(pIJ790) (containing the λRed system) is an E. coli 97 
K12 (ΔaraBAD, ΔrhaBAD) derivative (24) and non-methylating ET12567(pUZ8002) is 98 
a dam, dcm, hsdS, cat, tet strain harbouring the tra genes in the non-transmissible RP4-99 
derivative plasmid, pUZ8002 (25). Both strains were grown in Luria–Bertani (LB) 100 
liquid broth or on LB agar (26). For CDA bioassays a parent strain of Bacillus subtilis 101 
(CECT 4522) was grown as an overlay on NA medium (27). S. lividans 66, S. 102 
coelicolor M145 (prototroph, SCP1-, SCP2-) and mutant strains were grown on R2YE 103 
and MS solid media for transformation and sporulation respectively (28). The liquid 104 
cultures used for transcriptional profiling and ChIP-chip were grown in NB medium at 105 
30 ºC in 500 ml baffled flasks with 160 ml of medium each in a shaking orbital 106 
incubator (250 rpm). When necessary the media was supplemented with antibiotics (E. 107 
coli media: 100 µg ml-1 for ampicillin, 50 µg ml-1 for apramycin, 50 µg ml-1 for 108 
kanamycin, 34 µg ml-1 for chloramphenicol, and 25 µg ml-1 for nalidixic acid. S. 109 
coelicolor media: 20 µg ml-1 for neomycin, 50 µg ml-1 for apramycin, and 20 µg ml-1 for 110 
hygromycin). 111 
Nucleic acid manipulations 112 
Plasmid isolation, restriction enzyme digestion, ligation, and transformation of E. coli 113 
and S. coelicolor were carried out as described in Sambrook et al (26) and Kieser et al 114 
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(28), respectively. The plasmids and cosmids used are listed in Table S1. Total genomic 115 
DNA from S. coelicolor (gDNA) was isolated from a 24-36 h cultures in TSB medium 116 
following the procedure described in Hopwood et al (27), but scaled to 1-2 g of 117 
mycelium. 118 
When needed the DNA was sequenced on both strands using a Perkin Elmer ABI Prism 119 
377 DNA sequencer. In silico plasmid designs were obtained with the Gene 120 
Construction Kit software (GCK, Texco). 121 
Plasmid constructions 122 
Integrative plasmid pSETabrC3 was constructed by cloning the abrC3 gene under the 123 
regulation of its own promoter into the shuttle Streptomyces integrative plasmid 124 
pSET152.Tio using NdeI and BamHI restriction sites. This plasmid was used for 125 
complementation of the ∆abrC3 mutant strain (Table S1). 126 
The low copy number pHJLAbrC3 plasmid derived from pHJL401 (29) was obtained 127 
by cloning the abrC3 gene with its own promoter into pHJL401 using BamHI/EcoRI 128 
sites. 129 
The new plasmids were introduced into the corresponding Streptomyces strains by 130 
protoplast transformation as previously described (28). 131 
E. coli expression vector pETabrC3 was a derivative of pET22(b) plasmid, obtained by 132 
cloning the coding sequence for AbrC3 previously amplified by PCR with the 133 
corresponding oligonucleotides SRG-001 and SRG-002 (Table S2) in the NdeI/XhoI 134 
sites of the polylinker. 135 
AbrC3 over-expression in E. coli 136 
Cultures of E.coli BL21(DE3) transformed with pETabrC3 were induced with 1 mM 137 
IPTG to overproduce the AbrC3x6-His, subsequently purified with Ni-NTA (Qiagen) as 138 
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described before (30) and used to immunise two rabbits in order to obtain anti-AbrC3 139 
antibodies. 140 
Mutant construction (abrC3 knockout) 141 
The PCR-targeted system established by Gust et al. (31), was used to replace the 142 
complete coding sequence of abrC3 (SCO4596) located in cosmid SCD20 143 
(http://streptomyces.org.uk/) by the apramycin resistant gene aac(3)IV. The primers 144 
used to amplify the mutagenic cassette with pIJ773 as a template are listed in Table S2. 145 
The mutated cosmid SCD20∆abrC3::acc(3)IV obtained in E. coli BW25113(pIJ790) 146 
was demethylated in E. coli ET12567(pUZ8002) and transferred by conjugation to S. 147 
coelicolor M145. The desired double recombinants carrying apramycin resistance, 148 
while being sensitive to kanamycin (the selection marker for the vector sequences), 149 
were selected. Southern blotting and PCR assays confirmed the deletion of the abrC3 150 
gene in S. coelicolor M145. 151 
RNA isolation and DNA microarrays analysis  152 
For RNA extraction from S. coelicolor parent strain and ∆abrC3 mutant strains, 160 mL 153 
of NB media was inoculated in 500 mL baffled flasks with 4 x 106 spores/mL and 154 
incubated at 30 ºC for 36, 48, and 60 h. Two biological replicates and three technical 155 
replicates were used for each time-point. Prior to RNA isolation using a modified 156 
version of mirVana miRNA Isolation kit protocol (Life Technologies), cells from 20 157 
mL of culture were harvested and suspended in RNA-protect Bacteria Reagent 158 
(Qiagen). Following mycelial lysis with lysozyme (15 mg/ml in TE at room 159 
temperature), three vol. of RLT buffer from the RNeasy mini plus kit (Qiagen) were 160 
added and mycelia were disrupted using a TissueLyser (Qiagen) for 4 min. The lysate 161 
was clarified by centrifugation, extracted twice with phenol/chroroform and once with 162 
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chloroform and applied to a gDNA eliminator filter (RNeasy mini Plus, Qiagen) to 163 
remove any contaminating DNA. After this step 1.25 vol of 100 % ethanol were added 164 
and the total RNAs (including small RNAs) were purified through the mirVANA 165 
columns following the manufacturer’s recommendations. The quality and concentration 166 
of RNA were assayed using the Bioanalyzer 2100 system and spectrophotometric 167 
assays (Agilent and Nanodrop ND1000, respectively).  168 
The S. coelicolor IJISS 105K microarray used for ChIP-chip and high-resolution 169 
transcriptome analysis, was designed by the Functional Genomics Laboratory of Surrey 170 
University (UK) in collaboration with Oxford Gene Technology (UK), and 171 
manufactured by Agilent. They comprise almost 105,000 unique 60-mers with an 172 
average genome spacing of 35 nucleotides. The 105K probes are designed to cover the 173 
coding strands of all known protein coding genes and both strands of all intergenic 174 
regions. A cDNA versus reference gDNA microarray two-colour experimental design 175 
was utilised for the transcriptomic comparison of S. coelicolor M145 and ∆abrC3. All 176 
Cy3-cDNA and Cy5-gDNA labelling reactions and hybridisation assays were 177 
performed according to the recommendations described in 178 
http://www.surrey.ac.uk/fhms/microarrays/Downloads/Protocols/index.htm 179 
All hybridised arrays (expression and ChIP-chip) were scanned using an Agilent 180 
Technologies microarray scanner and resultant images were analysed using Agilent 181 
Technologies Feature Extraction software (version 9.1.3.1.) with local background 182 
correction.  183 
Raw gene expression data were normalised within the statistical computing 184 
environment R using the LIMMA package (32-34) global median within-array 185 
normalization, followed by the ‘scale’ across-array normalization was applied. Probes 186 
that were flagged as poor quality by Agilent Feature Extraction were removed from the 187 
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analysis. A gene’s expression was calculated by averaging across all remaining good 188 
quality probes that target the annotated coding sequence. Expression data sets were 189 
analysed using rank products analysis via RankProdIt (http://strep-190 
microarray.sbs.surrey.ac.uk/RankProducts), a web-interactive analysis tool (35). 191 
Differentially expressed genes were identified as having a pfp (probability of false 192 
prediction) value less than or equal to 0.15, equal to a false discovery rate of 193 
approximately 15 % and at a level that has been experimentally validated (in this study) 194 
and others (e.g. (36). A BED formatted track with the average Log2 expression data to 195 
be visualised across the chromosome using the UCSC microbial gene browser 196 
(http://microbes.ucsc.edu/) was generated using in-house Perl scripts. All data are 197 
MIAME compliant and the raw and normalized data have been deposited in 198 
ArrayExpress (accession number E-MTAB-1453). 199 
 200 
qRT-PCR  201 
Real-time quantitative RT-PCR (qRT-PCR) was used to validate the microarray data. 202 
Specific primers and probes for the tested genes were designed using the Primer3 web-203 
based tool (Table S2). Five-µg RNA samples were treated with RNAase-free DNaseI 204 
(Promega) according to the manufacturer instructions. One µg of the resulting RNA was 205 
used as template for cDNA synthesis using iScript Reverse Transcription Supermix for 206 
RT-qPCR (Bio-Rad) in 20 μl reaction volumes. The samples were diluted 1:1 with 207 
distilled water and 5 μl was used in the quantitative PCR reaction with 10 pmol of 208 
forward and reverse primer, 2.5 pmol of FAM/TAMRA dual-labelled specific probe, 209 
and 12.5 μl SsoFastTM Probes Supermix with ROX master mix (Bio-Rad) in a final 210 
volume of 25 μl. Each assay was performed in duplicate using CFX96 Touch™ Real-211 
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Time PCR Detection System (Bio-Rad). Control PCRs were included to verify that 212 
there was no DNA contamination (without RT, enzyme negative control). Relative 213 
quantification of gene expression was performed by the ∆∆Ct method, a comparative 214 
qPCR data analysis (37) in which, the Ct values of the genes of interest obtained from 215 
two different experimental RNA samples (parent strain and mutant) are directly 216 
normalized to the Ct values of a housekeeping gene (gene control) in the same samples. 217 
First, the difference between the Ct values of the gene of interest between parent and 218 
mutant strains (∆Ct1) and difference of Ct values of the housekeeping gene between 219 
both strains (∆Ct2) are calculated for each experimental sample. Then, the difference in 220 
the ∆Ct values between the gene of interest and control gene (∆Ct1-∆Ct2 = ∆∆Ct) is 221 
calculated. The fold-change in expression of the gene of interest between the two 222 
experimental samples (parent strain and mutant) is then equal to 2-∆∆Ct. The gene hrdB 223 
(SCO5820) was the internal control used to quantify the relative expression of the target 224 
genes, since its expression level remained constant in all the conditions analyzed by 225 
microarray. The expression ratios measured by microarrays and by qRT-PCR assay 226 
were plotted, and the linear correlation coefficient was calculated (y = 1.60x – 0,09; R2 227 
= 0.93) (Table 3).  228 
 229 
ChIP-chip analysis 230 
For Chromatin Inmunoprecipitation (IP) three aliquots of 20 mL from the same cultures 231 
used in the microarray gene expression analysis were taken (S. coelicolor M145 and 232 
∆abrC3 mutant strains incubated at 30 ºC for 36, 48, and 60 h). These samples were 233 
treated with formaldehyde (Sigma) at a final concentration of 1 %. Crosslinking was 234 
allowed to proceed for 30 min at 30 ºC. Glycine, at a final concentration of 0.5 M was 235 
added to stop the crosslinking for a further 5 min at 30 ºC. Mycelium was harvested by 236 
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centrifugation and frozen at -20 ºC. Chromatin of average size range 300-600 bp was 237 
obtained as described in Bucca et al (38). Chromatin IP was carried out as described 238 
before (38) using purified rabbit polyclonal antibodies against AbrC3 obtained in our 239 
laboratory. The IgG fraction containing anti-AbrC3 polyclonal antibodies and the 240 
fraction from preimmune serum from the same rabbit used for immunisation was 241 
purified by affinity chromatography using CNBr activated Sepharose 4B (Sigma). The 242 
chromatin purified from S. coelicolor M145 and ∆abrC3 mutant strains was sonicated 243 
to obtain an average size range of 300-600 bp. DNA samples were immunoprecipitated 244 
with either AbrC3 antibodies (abIP) or mock control (NoIP), purified, labelled with Cy3 245 
or Cy5-dCTP respectively and hybridized to 105K arrays as described above. Two 246 
biological replicates were hybridized such that the AbIP/NoIP samples from each of the 247 
two replicates were labeled in opposite dye orientations to control for dye bias. Arrays 248 
were scanned and processed as described above. 249 
The raw data were normalized within R (as above) using the across-array scale function 250 
of the LIMMA package only. Again, poor quality probes were filtered out from 251 
downstream analysis. The data analysis was carried out essentially as described by 252 
Allenby et al. (39). Significant probes (p < 0.05) defined on the basis of a non-253 
parametric t-test run with ‘multtest’ and ‘pnorm’ (within R) were plotted as ratio of 254 
[(parent strain Ab IP/mock IP) / (∆abrC3 Ab IP/mock IP)]. The probes most 255 
differentially-enriched for AbrC3 binding between the parent strain and the mutant were 256 
selected from the right tail of the distribution. Probes within 3 kb (based on their 257 
annotated genomic location) of each other were ‘grouped’ and genomic regions of 258 
interest were those in which at least two enriched probes were found. Finally, tracks 259 
(BED files) to visualise the data across the chromosome using the UCSC microbial 260 
genome browser (http://microbes.ucsc.edu/) were generated using in-house Perl scripts. 261 
 12
The raw and normalized ChIP-chip data have been deposited in ArrayExpress 262 
(accession number E-MTAB-1451). 263 
 264 
Western blot assays 265 
Total protein extracts were obtained from 5 mL samples (in triplicate) of the cultures 266 
used for the global analysis described above. The proteins were resolved in SDS-PAGE 267 
(15 % polyacrylamide in a MiniProtean II system, BioRad). After transfer to Inmobilon-268 
P (Millipore) the proteins were reacted with pre purified polyclonal 1:100000 dilution 269 
of anti-AbrC3. AbrC3 was detected by chemiluminescence with ECL western blotting 270 
detection reagents following the manufacturer’s instructions (GE Healthcare) using 271 
horseradish peroxidase-coupled anti-rabbit secondary antibody. 272 
 273 
In vitro DNA-binding assays  274 
Gel-shift assays were conducted using DNA fragments containing the intergenic region 275 
(up to -400 bp from the translational start point) plus 100 (+ 100 inside the ORF) were 276 
amplified using the corresponding primers in a PCR reaction (Table S2). These 277 
fragments were 5’-radiolabelled with T4 polynucleotide kinase in the presence of [γ-278 
32P]-dATP, and the unreacted [γ-32P]-dATP was removed using Illustra ProbeQuant TM 279 
G-50 Micro Columns (GE HealthCare, USA). The purified proteins were incubated in 280 
Tris-HCl 50 mM pH 7, MgCl2 25 mM, NaCl 0.1 M at 30 ºC for 30 min, prior to the 281 
binding. Then, different concentrations of the proteins were incubated with the labelled 282 
DNA probes (10 fmol) in binding buffer (Tris-HCl 10 mM pH 7.8, DTT 2 mM, NaCl 283 
150 mM, glycerol 10 % and 45 ng of sheared salmon sperm DNA) for 30 min at 30 ºC. 284 
Protein bound DNA and free DNA were resolved on 5 % acrylamide gel in 0.5 X TBE 285 
buffer (Tris 44,5 mM, boric acid 44,5 mM, EDTA 1 mM pH 8) at 4º C. The gel was 286 
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exposed overnight and autoradiography revealed. As control, unlabelled specific probe 287 
(S) (100-fold molar excess) or non-specific competitor DNA (N) (100-fold molar excess 288 
of sheared salmon sperm DNA) were added to the reaction mixture. Also a BSA protein 289 
binding reaction (4 µM) was conducted as a control to demonstrate the specificity of the 290 
EMSAs. 291 
 292 
Identification of the putative AbrC3 binding site 293 
The Regulatory Sequence Analysis Tools (RSAT) “consensus” alignment  294 
(http://rsat.ulb.ac.be/) was used to identify putative DNA conserved sequences in the 295 
upstream regions (with respect to the annotated translation start codon) of the AbrC3 296 
target genes (including 100 bp into the respective ORF), identified from the ChIP-chip 297 
experiment.  298 
The functionality of the conserved ten-base sequence, identified with RSAT consensus 299 
alignment, was demonstrated by eliminating it from the actII-ORF4p p. The elimination 300 
of this sequence was achieved using overlapping PCR. As a first step, PCR amplicons 301 
were made using primers SRG95/SRG97 and SRG96/SRG90, respectively (Table S2). 302 
Using both resulting fragments as templates, a second PCR was conducted using 303 
oligonucleotides SRG95/SRG90. The final fragment, with EcoRI/PstI sites in the ends, 304 
was cloned into the pGEM T-easy plasmid. The elimination of the consensus binding 305 
sequence from the absR1p was performed by PCR amplification of the region with the 306 
oligonucleotides SRG-116/SRG073 (Table S2). 307 
 308 
Antibiotic production measurements 309 
Production of ACT in liquid cultures was determined measuring A640 (ε640= 25320) in 310 
the supernatant of samples treated with 1N KOH overnight at 4 ºC and centrifuged 311 
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(15000 g, 10 min). The experiments were all performed in triplicate and the dry weight 312 
of samples at different times was measured to monitor culture growth. 313 
Chromatographic analysis  314 
Liquid cultures were centrifuged and supernatants and cell pellets were extracted 315 
separately. The supernatants were extracted twice with an equal volume of ethyl acetate 316 
containing 1% formic acid. The cell pellets were extracted with acetonitrile. In each 317 
case, the solvent was evaporated and the residue re-dissolved in a small volume of a 318 
mixture of dimethyl sulfoxide and methanol (50:50). These samples were 319 
chromatographed as previously described (40). 320 
 321 
RESULTS 322 
Influence of the AbrC3 RR in antibiotic production in Streptomyces  323 
The S. coelicolor ∆abrC3 mutant strain was generated using the PCR-targeting 324 
approach described by Gust et al. (31), which replaced the entire coding region of the 325 
gene with an apramycin resistance cassette (see Materials and Methods). Phenotypic 326 
analysis of growth and antibiotic production of the parent strain (M145 strain), ∆abrC3 327 
and the triple mutant ∆abrC1/C2/C3, previously described (13), revealed significant 328 
differences among the three strains (Figure 1A). ACT and RED production were highly 329 
diminished in both the triple and single mutant compared to the parent strain on nutrient 330 
agar medium. In contrast, CDA production in the mutant lacking only the response 331 
regulator, ∆abrC3, was unaffected while it was clearly diminished in the triple mutant. 332 
A delay in morphological differentiation on solid medium was also observed in both 333 
mutants. When the strains were grown in liquid nutrient broth (NB) the ∆abrC3 mutant 334 
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produced almost no ACT. Complementation of the ∆abrC3 mutant with the integrative 335 
plasmid pSET152-abrC3 restored ACT production to almost parent strain levels (Figure 336 
1B). Both mutants and the parent strain produced similar growth curves (e.g., Figure 337 
S1A) indicating that growth per se was not compromised in the mutant strains. 338 
Complementation with pSET152-abrC3 was also tested on solid medium (NA). ACT 339 
production and morphological differentiation were complemented and there was a 340 
partial complementation of RED production (Figure 1B). It was noted that ACT 341 
production on solid medium was found to be higher in the complemented strain than in 342 
the parent strain harbouring the empty plasmid; pSET152-derivates tend to exist as 343 
tandem duplications in the genome (CPS, unpublished data) and it is therefore 344 
conceivable that an enhanced level of AbrC3 is responsible for the elevated ACT 345 
production.  346 
It is noteworthy to mention that quantification of ACT production from M145 cells 347 
transformed with abrC3 moderately overexpressed from the low copy number plasmid, 348 
pHJLabrC3 plasmid, showed 33% more ACT production at five days compared to the 349 
plasmid control, pHJL401 (Figure 2). This result was consistent with AbrC3 acting as a 350 
positive regulator of the ACT gene cluster and offers the possibility of using this low 351 
copy number plasmid to enhance antibiotic production. Indeed, when pHJLabrC3 was 352 
introduced into the S. lividans 66 strain, the normally silent ACT pathway was induced 353 
to even higher levels than in S. coelicolor (Figure 2). 354 
 355 
Effects of abrC3 deletion on the S. coelicolor transcriptome 356 
Comparison of genome-wide mRNA abundances between the parent strain S. coelicolor 357 
M145 and its congenic ∆abrC3 mutant was performed. Samples from 36, 48, and 60 h 358 
growth (Figure S1-A) were taken and antibiotic production at these time points was 359 
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assessed by HPLC. As shown in Figure S1-B, at 60 h growth there was an ACT 360 
production peak in the parent strain but not in the mutant strain, in both the supernatant 361 
and cell extract fractions. Likewise, RED production was only observed in parent strain 362 
cell extracts. In addition, the level of AbrC3 protein in the parent strain and its absence 363 
in the mutant ∆abrC3 strain at the three sampling points used in this study was 364 
confirmed by Western blotting using anti-AbrC3 antibodies (Figure S1-C).  365 
Total RNA samples from the ∆abrC3 mutant and the parent strain cultivated at 36, 48, 366 
and 60 h in NB medium were labelled and hybridized to 105K × 60-mer high density 367 
whole genome S. coelicolor IJSS DNA microarrays as described by Lewis et al. (41) 368 
(see Materials and Methods). Analysis of the DNA microarray data from two 369 
independent experiments revealed that only 32 genes were down-regulated and eight 370 
genes were up-regulated at a statistically significant level (Benjamini and Hochberg 371 
corrected p-values <0.005 and pfp <0.15 (pfp: probability of false prediction)) (see 372 
Tables 1 and 2). Of the 33 genes that showed a significantly reduced expression in the 373 
mutant strain, 16 corresponded to the entire act cluster, including actII-ORF4 374 
(SCO5085), which encodes the SARP pathway-specific regulator of the act cluster 375 
(Table 1). Three other significantly down-regulated genes encode regulatory proteins 376 
and were previously related to antibiotic regulation, sIHF (SCO1480) (15, 16), afsS 377 
(SCO4425) (17, 18), and absR1 (SCO6992) (19). An additional gene encoding a 378 
putative transcriptional regulator with a helix-turn-helix motif, SCO1839, and two genes 379 
involved in morphological development, wblE (SCO5240, encoding an extra-380 
cytoplasmic function sigma factor (20, 21)) and bdtA (SCO3328, encoding a putative 381 
transcription factor regulated by BldD, and that forms an operon with SCO3327 (22, 382 
23)) were also significantly down-regulated. The acdH gene (SCO2779) encoding an 383 
acyl-CoA dehydrogenase involved in branched amino acid catabolism in S. coelicolor 384 
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and S. avermitilis (42) and SCO3218, a gene of unknown function located in the cda 385 
gene cluster, were also significantly down-regulated in the mutant (Table 1). Among the 386 
eight genes significantly up-regulated were the ribosomal protein gene, rplP (SCO4709) 387 
and chpE (SCO1800) (43) (see Table 2). 388 
Several of the differentially expressed genes were selected for independent validation 389 
by quantitative real time PCR (qRT-PCR) (Table 3). These included down regulated 390 
genes: acdH (SCO2779) acyl-CoA dehydrogenase, absR1 (SCO6992) activator of 391 
secondary metabolism, a sigma-like protein gene afsS (SCO4425), and the specific 392 
regulator of the ACT cluster, actII-ORF4 (SCO5085). We also analyzed the expression 393 
levels of one of the genes differentially up-regulated in the mutant that encodes the 50S 394 
ribosomal protein L16 rplP (SCO4709). Moreover, we included both histidine kinase 395 
genes of the TCS, abrC1 and abrC2 (SCO4598 and SCO4597), in order to confirm their 396 
non-differential expression levels. A good correlation of transcript measurements from 397 
the microarray data and the qRT-PCR data (yielding a correlation regression coefficient 398 
of 0.93) was obtained (Table 3). Note that the validation of differential expression for 399 
SCO4709 confirms the use of 0.15 as a suitable pfp threshold for determining 400 
significance, similar to that found in other expression based studies (e.g. (36)). 401 
 402 
In vivo identification of AbrC3 targets on the S. coelicolor genome  403 
The genes exhibiting a marked AbrC3-dependent change in expression could be directly 404 
regulated by AbrC3 or could be regulated by transcription factors downstream of AbrC3 405 
in a possible regulatory cascade. Hence, to identify genes directly regulated by AbrC3, 406 
by interaction with their respective promoter regions, a genome-wide ChIP-chip 407 
approach was undertaken. Samples from the same cultures and time-points used for the 408 
transcriptomic analysis (above), were treated with formaldehyde to cross-link proteins 409 
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to DNA and subjected to chromatin immunoprecipitation with either purified anti-410 
AbrC3 antibodies or mock controls (see Materials and Methods). The 411 
immunoprecipitated DNA from each strain was labelled with Cy3 or Cy5 in a dye-412 
balanced direct comparison experimental design and hybridized to the above mentioned 413 
105K S. coelicolor microarrays (see Materials and Methods). Two biological replicate 414 
experiments were conducted and significantly enriched genomic binding regions in the 415 
parent strain relative to the ∆abrC3 mutant were identified. We identified 617, 520, and 416 
458 AbrC-enriched (AbrC3 DNA targets bound at significant higher levels when 417 
comparing parent strain to the mutant) regions from chromatin isolated at 36 h, 48 h, 418 
and 60 h of growth, respectively. The genes with higher enrichment ratio are 419 
summarized in Table 4 and the overlapping targets in ChIP-chip and transcriptome 420 
analyses in Table 5. 421 
This analysis demonstrates that the AbrC3 protein is able to bind in vivo to the promoter 422 
of the pathway-specific regulator gene of the ACT cluster, actII-ORF4p, (SCO5085) 423 
(Table 4 and 5) at 36 h with high efficiency. No binding was detectable at 48 h or 60 h. 424 
This result suggests that the down-regulation of the act gene cluster (Table 1) is due to 425 
the direct regulation of actII-ORF4 exerted by AbrC3 at around 36 h culture time.  426 
Efficient binding of AbrC3 to its own promoter abrC3p (SCO4596) at 60 h was also 427 
observed (Table 5), indicating that AbrC3 is an autoregulator. No binding to the 428 
promoters of the histidine kinase-encoding genes of the AbrC system (abrC1 and 429 
abrC2), nor differential expression of these two genes under the experimental 430 
conditions used, was observed (Table 3). 431 
In vivo binding of AbrC3 to several of the promoters of the genes previously identified 432 
as down-regulated was observed and therefore their expression is very likely to be 433 
directly controlled by AbrC3 (Table 5). Weaker AbrC3-enrichment was observed 434 
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upstream of genes SCO1480 (sIHF), SCO1550, the regulator SCO1839, the acyl-CoA 435 
dehydrogenase AcdH (SCO2779), and the transcription factor WblE (SCO5240), and no 436 
binding at all was observed for three of the differentially expressed genes identified in 437 
our transcriptome analysis: SCO0682, SCO3218, and afsS (SCO4425) (data not shown). 438 
We hypothesize that these genes could be regulated by factors downstream of AbrC3 in 439 
a possible regulatory cascade, or additional transcription factors/co-factors bound to the 440 
promoter regions blocked access of the anti-AbrC3 antibody, yielding false negatives 441 
(see, for example, (39)).  442 
Among the significantly up-regulated genes, we could only detect binding of AbrC3 to 443 
the putative promoters of the rplP (SCO4709) and SCO6809 genes (Table 5), 444 
suggesting that the other six up-regulated genes may be regulated by factors 445 
downstream.  446 
Electrophoretic mobility shift assays (EMSAs) were conducted to test the in vitro 447 
binding capacity of the protein to the DNA sequences upstream of the corresponding 448 
genes that showed AbrC3-binding in vivo. DNA fragments comprising intergenic region 449 
(up to -400 bp from translation start point) plus 100 bp inside the ORF (+100) were 450 
used to perform the experiments and were so on called promoters* (SCOXXXXp). Most 451 
of the identified targets that were bound in vivo by the AbrC3 protein (Table 5) were 452 
also able to be bound in vitro with high specificity: actII-ORF4p, abrC3p, SCO0736p, 453 
absR1p, and SCO6809p (Figure 3A, 3B, 3C, 3D and 3H). The promoters* of SCO2113 454 
and bdtA were bound with less specificity (Figure 3E and 3F) and some putative 455 
promoters*, such as SCO4709p, did not yield mobility shifts in vitro (Figure 3G). 456 
Competition experiments to verify the specificity of AbrC3 binding, to each promoter*, 457 
were conducted by adding different amounts of the corresponding unlabelled DNA or 458 
different amounts of sheared salmon sperm DNA to the binding reaction. 459 
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 460 
Identification of a putative consensus AbrC3 binding site 461 
Aligning the 500 bp upstream sequences (including the first 100 bp of the respective 462 
ORFs) of genes enriched for AbrC3 in the ChIP-chip and EMSA analyses using the 463 
Regulatory Sequence Analysis Tools consensus alignment (http://rsat.ulb.ac.be/) 464 
identified a minimal consensus-binding site for AbrC3. A common 10 bp sequence (5’-465 
GAASGSGRMS-3’) was present in all of the putative promoters of the identified target 466 
genes and was absent in the ones that did not yield mobility shifts in vitro, such as 467 
SCO4709p (Figure 4A). This putative AbrC3-binding sequence was present within the 468 
ORF of actII-ORF4, in the positions +72/+81 (from the translation start codon), near 469 
one of the described target sequences of the regulator AtrA (44) (Figure 5). This 470 
sequence was also found in 23 out of 30 of the genes identified by ChIP-chip (Table 4).  471 
The functionality of this putative AbrC3-binding sequence was demonstrated by 472 
EMSAs using different fragments of the actII-ORF4p or deleting the putative binding 473 
sequence (Figure 4B). Only the whole promoter* region (fragment 1 used also in Figure 474 
3), or a 3′ part of the promoter* that included the ten-base sequence generated a 475 
mobility shift in the presence of the AbrC3 protein (Figures, 4B panels 1 and 4). 476 
Conversely, the mobility shift did not take place when the ten-base sequence was 477 
removed (see Materials and Methods) (Figure 4B panel 5); controls used to demonstrate 478 
the specificity of AbrC3-binding to the 3′ segment of the promoter* (fragment 4) are 479 
shown in Figure 4C. This result clearly indicated that the sequence (5’-480 
GAAGGCGACC-3’) was essential in the direct regulation of the actII-ORF4 expression 481 
by the AbrC3 regulator.  482 
The importance of this sequence in the binding of AbrC3 was also demonstrated by 483 
EMSA with absR1p, another direct target of this regulator. The elimination of the 484 
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proposed binding-sequence (5’-GAAGGGGACG-3’) originated the sequence 485 
absR1pDel unable to bind AbrC3, and therefore the shifted band was not observed. 486 
(Figure S2). 487 
Moreover, EMSAs were performed using shorter DNA probes consisting in a 50 bp 488 
labeled oligonucleotide (resulted from annealing two complementary long 489 
oligonucleotides SRG119/120 (Table S2)) corresponding to a small fragment from 490 
actIIORF4p and containing the predicted binding sequence (probe 1) and also another 491 
artificial labeled oligonucleotide with the same size containing this sequence but 492 
surrounded by foreign DNA (probe 2: annealing of oligonucleotides SRG121/122 493 
(Table S2)). The results (Figure S3) showed the ability of AbrC3 to bind specifically to 494 
probe 1 and also to the artificial probe 2. Therefore these 10 nucleotides (5’-495 
GAAGGCGACC-3’) were enough to recruit the protein. 496 
DISCUSSION 497 
AbrC3 directly regulates actII-ORF4 expression 498 
An integrated global ChIP-chip and transcriptome analysis of parent strain S. coelicolor 499 
and an abrC3 mutant derivative has identified the regulon of the response regulator 500 
AbrC3. actII-ORF4, the pathway-specific regulator of ACT, is one of its direct targets 501 
as corroborated by EMSA in vitro. A 10 bp sequence, 5’-GAASGSGRMS-3’, identified 502 
by RSAT consensus alignment of the putative promoters* targeted by AbrC3 defines 503 
the AbrC3 binding site. In the case of actII-ORF4, the binding sequence (5’-504 
GAAGGCGACC-3’) is found within the ORF at the position +72/+81 (from the 505 
translational starting ATG) (Figure 5). It is not the first time that a transcriptional 506 
regulator-binding site is found within the actII-ORF4 coding sequence; there are two 507 
other regulators, AtrA and Crp, whose binding sites are in position +45/+69 (44) and 508 
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+24/+38 (45), respectively. DNase footprinting assays using selected AbrC3 associated 509 
sequences failed to yield a DNase-protected region (data not shown); we consider that 510 
the observed poor solubility of AbrC3 in vitro may account for the incomplete shifting 511 
of template DNA obtained in the EMSAs and for our failure to observe a footprint. 512 
Nevertheless, this consensus sequence has been shown indispensable for AbrC3 binding 513 
to the actII-ORF4p (Figure 4) and for another of its targets (absR1p) (Figure S2). We 514 
speculate that binding of AbrC3 to the actII-ORF4p at 36 h may be necessary for the 515 
recruitment of other regulators and that the binding of these is necessary for the first 516 
steps of actII-ORF4 expression: after this initial ‘recruitment’ the regulators are 517 
subsequently released from the promoter* to allow expression of downstream genes. 518 
The expression of the ACT-specific pathway regulator actII-ORF4 is under the control 519 
of different regulatory proteins that respond to diverse signaling routes in S. coelicolor 520 
such as PhoP/R (46) and RapA1/A2 (47), LAL regulators SCO0877 and SCO7173 (48), 521 
ECF SigT (49), among others (reviewed by van Wezel and McDowall (3)). To date, 522 
demonstration of the direct binding of transcription factors to the actII-ORF4 promoter 523 
region is limited (Figure 5). In vitro binding assays (EMSAs) have shown that the AtrA 524 
protein binds to the actII-ORF4 promoter (44). More recently, DNA affinity capture 525 
assays have shown the capability of four more proteins (SCO0310, SCO3932, 526 
SCO5405 and AdpA) to bind to the actII-ORF4 promoter (15). Among the TCSs 527 
implicated in antibiotic production only AbsA2 has, thus far, been shown to bind to the 528 
actII-ORF4 promoter in vivo (50). Very recently, EMSAs have demonstrated the in 529 
vitro binding of the TCSs DraR/K and AfsQ1/Q2 to the actII-ORF4 promoter (51, 52). 530 
Control of secondary metabolism by the global regulator Crp has also recently been 531 
described and Crp binding to actII-ORF4 detected by ChIP-chip, being both of the two 532 
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binding sites described within the ORF, in positions +24/+38 and +234/+248 (Figure 5) 533 
(45). 534 
AbrC3 regulon 535 
The putative binding sequence (5’-GAASGSGRMS-3’) defined in this work is present 536 
in 23 out of 30 genes with the highest binding enrichment (WT AbIP/NoAbIP vs 537 
∆abrC3 AbIP/NoAbIP enrichment ratio obtained in the ChIP-chip assay) (Table 4). The 538 
position of the putative binding sequence is typically upstream of the respective ORF 539 
suggesting regulation of the gene downstream of the binding site. However, in some 540 
cases the target sequences are within the coding sequences. This feature is coincident 541 
with data described previously in the study of the regulation exerted by the protein Crp 542 
where more than 50 % of all Crp-associated sequences were mapped within ORFs (45). 543 
The regulatory role of these sequences located inside the ORFs is not clear and in a 544 
recent study, using ChIP-seq and ChAP-seq technologies to characterize the AdpA 545 
regulon, it was found that approximately 75 % of the in vivo AdpA-binding sites 546 
apparently have no function in the regulation of gene expression (53).  547 
Conversely, it is also possible that some bona fide AbrC3 targets were missed in this 548 
study because the antibody does not recognize the epitopes when AbrC3 is one of 549 
several transcription factors bound to the promoter regions. It is known that false 550 
negatives can occur in ChIP-chip studies (38).  551 
 552 
Pleiotropic regulation by the abrC TCS 553 
The pleiotropic phenotype of the triple ∆abrC1/2/3 mutant (13) shows relative 554 
differences (decreased CDA production) when compared to the phenotype of the RR 555 
gene deletion mutant, ∆abrC3. This result suggests that other RRs may be controlled by 556 
the kinases of this TCS such as the orphan RR SCO2281 proposed by Wang et al to be 557 
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recognized by AbrC2 (54). It is known that the biosynthetic RED genes are expressed 558 
early, so the existence of AbrC3 direct regulation to the promoter regions of redD or 559 
redZ cannot yet be excluded with the experimental conditions tested. If the RED cluster 560 
regulation by AbrC3 is indirect, this could be exerted through the regulatory cascade 561 
triggered by AfsS, that is one of the indirect AbrC3 targets (17, 18), or by sIHF, down-562 
regulated in ∆abrC3 and able to bind to the redD and redZ promoters (15, 16).  563 
Several transcriptional regulators, whose encoding genes were down-regulated in our 564 
study could be responsible of the morphological phenotype observed in the ΔabrC3 565 
mutant: sIHF that also binds to the bldD promoter, a key regulator of development in S. 566 
coelicolor (16); the extracytoplasmic function sigma factor, WblE (20, 21); and BdtA a 567 
putative transcription factor regulated by BldD involved in morphological 568 
differentiation (22, 23).  569 
ChIP-chip assays demonstrated that AbrC3 is an autoregulator. No differential 570 
regulation between the wild type strain and the AbrC3 mutant of the two kinase-571 
encoding genes of the AbrC TCS system was identified in our ChIP-chip or 572 
transcriptome analysis.  573 
A summary of the main interactions within the AbrC3 regulon deduced from our global 574 
in vivo analyses (ChIP-chip and transcriptome analysis) is illustrated in the model 575 
depicted in Figure 6. We have observed a global positive effect on secondary 576 
metabolism, mainly on the ACT cluster, and morphological differentiation through the 577 
direct interaction of AbrC3 with the different genes mentioned above. This activation 578 
could also be facilitated by a negative control of AbrC3 on primary metabolism through 579 
ribosomal proteins such as RplP. Indeed, another gene involved in primary metabolism, 580 
acdH, is down-regulated in the ∆abrC3 mutant; this gene encodes an Acyl-CoA 581 
dehydrogenase involved in biosynthesis of precursors of ACT and RED and that could 582 
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explain the positive regulation of this gene by AbrC3. Besides, Wang et al. have just 583 
reported in vitro evidence that abrC3 is a target of AfsQ1 and that it positively regulates 584 
its expression. This suggests that the function of AfsQ1/Q2 is at least partly mediated 585 
via the AbrC1/C2/C3 system, further illustrating the complexity of the regulatory 586 
network governing antibiotic production (Figure 6) (51, 52).  587 
The emergence of new antibiotic resistant isolates makes new antibiotic discovery and 588 
the improvement of their production major challenges for microbial biotechnology. 589 
Widening our knowledge regarding TCS involvement in antibiotic synthesis regulation 590 
can contribute to the rational design of new hyper-producer host strains through genetic 591 
manipulation of those complex systems. Moreover, strategies involving TCS could be 592 
used to unveil new antimicrobial molecules that are not normally produced under 593 
laboratory culture conditions. 594 
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SUPPLEMENTARY DATA 608 
Figure S1: Phenotypic features of cultures used for ChIP-chip and transcriptome 609 
analysis. A) Growth curves of parent strain M145 and ∆abrC3 strains in NB medium at 610 
30 ºC. The cultures times selected for RNA isolation are encircled. B) HPLC profiles of 611 
60 h samples showing ACT and RED antibiotic production in M145 (black) and 612 
∆abrC3 (grey) strains. C) Western blot of the samples selected (36, 48 and 60 hours) in 613 
two biological duplicates using anti-AbrC3 antibodies. 614 
Figure S2: EMSA of AbrC3 protein with absR1p and absR1pDel (the same region 615 
without the putative proposed binding-sequence, 5’- GAAGGGGACG -3’).  616 
Figure S3: EMSA of AbrC3 protein with actII-ORF4 50-bp oligonucleotide containing 617 
the proposed binding-sequence (5’-GAAGGCGACC-3’) (Probe 1) and an artificial 50-618 
pb oligonucleotide including this sequence (5’-GAAGGCGACC-3’) but surrounded by 619 
foreign DNA (Probe 2).  620 
Table S1: Plasmids and cosmids used in this work 621 
Table S2: Oligonucleotides used in this work  622 
623 
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TABLES  804 
TABLE 1 - Selected genes significantly down-regulated in the ∆abrC3 mutant relative 805 
to parent strain, M145 (p-value< 0.005 and/or pfp*<0.15) 806 
SCO/name Function p-value pfp Fold 
change 
Time 
(hours) 
5071 Hydroxylacyl-CoA dehydrogenase 0 0.002 -1.77 48 
5072 Hydroxylacyl-CoA dehydrogenase 0 0 -2.13 48 
5073 Putative oxidoreductase 0 0 -2.09 48 
5074 Putative dehydratase 0 0 -3.25 48 
5075/ORF4 Putative oxidoreductase 0 0 -2.23 48 
5077/actVA2 Hypothetical protein 0 0.001 -1.99 48 
5078/actVA3 Hypothetical protein 0 0 -2.28 48 
5079/actVA4 Conserved hypothetical protein 0 0 -2.28 48 
5080/actVA5 Putative hydrolase 0 0 -2.25 48 
5081/actVA6 Hypothetical protein 0 0 -2.59 48 
5085/actII-ORF4 Actinorhodin cluster activator protein 0 0 -2.85 48 
5086/actIII Ketoacyl reductase 0 0 -2.80 48 
5087/actIORF1 
Actinorhodin polyketide beta-ketoacyl synthase alpha 
subunit 
0 0.008 -1.83 48 
5088/actIORF2 Actinorhodin polyketide beta-ketoacyl synthase beta 
subunit 
0 0.003 -1.92 48 
5089/actIORF3 Actinorhodin polyketide synthase acyl carrier protein 0 0 -3.11 48 
5090/actVII Actinorhodin polyketide synthase bifunctional 
cyclase/dehydratase 
0.0002 0.060 -1.63 48 
0045 Hypothetical protein 0.0005 0.127 -1.23 48 
0682 Hypothetical protein SCF15.03c 0.0001 0.053 -1.25 48 
0736 Putative secreted protein 0 0.019 -1.45 60 
1480/sIHF Streptomyces Integration Host Factor 0.0003 0.090 -1.28 48 
1550 Putative small membrane protein 0.0002 0.070 -1.35 36 
1839 Putative transcriptional regulator 0.0005 0.120 -1.40 36 
2113/bfr Putative bacterioferritin 0.0001 0.050 -1.24 48 
2779/acdH Acyl-CoA dehydrogenase 0.0006 0.145 -1.27 36 
3218 Putative small conserved hypothetical protein 0 0.018 -1.39 36 
3327 Hypothetical protein 0.0002 0.051 -1.41 60 
3328/bdtA Hypothetical protein 0.0002 0.055 -1.47 60 
4425/afsS Sigma-like protein 0 0.001 -1.83 48 
5240/wblE Hypothetical protein 0.0007 0.158 -1.36 48 
5915 Fatty acid desaturase 0.0003 0.081 -1.39 36 
6205 Putative threonine dehydrogenase 0.0007 0.158 -1.43 48 
6992/absR1 Regulatory protein 0.0001 0.056 -1.57 60 
* pfp: probability of false prediction 807 
 808 
  809 
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 810 
TABLE 2 - Selected genes up-regulated in the ∆abrC3 mutant relative to the parent 811 
strain, M145 (p-value< 0.005 and/or pfp*<0.15) 812 
SCO/name Function p-value Pfp Fold change Time 
1800/chpE Putative small secreted protein 0.0001 0.145 1.12 48 
2605 Hypothetical protein SCC88.16 0.0002 0.140 1.36 36 
4187 Putative membrane protein 0 0.040 1.52 36 
4709/rplP 50S ribosomal protein L16 0.0001 0.119 1.16 36 
6329 Hypothetical protein SC10H5.05 0.0001 0.115 1.38 60 
6809 
Putative integral membrane transport 
protein 
0.0001 
0.124 1.41 60 
7665 Hypothetical protein 0.0002 0.131 1.07 36 
7801 Putative membrane protein 0.0002 0.131 1.39 60 
* pfp: probability of false prediction 813 
 814 
 815 
TABLE 3. qRT-PCR validation of five differentially expressed genes identified from 816 
microarray data. Linear regression fit analysis was applied and correlation 817 
coefficient used to validate the data (y = 1.60x – 0,09; R2 = 0.93) 818 
SCO/name Function 
Expression ratios (fold change)a 
Microarray  RT-qPCR 
2779/acdH Acyl-Coa dehydrogenase -1.27 -2.13 
4425/afsS Sigma like protein -1.83 -3.06 
4597/abrC2 Sensor kinase -1.085 -1.12 
4598/abrC1 Sensor Kinase -1.04 -1.08 
5085/actII-ORF4 ACT cluster activation protein -2.85 -3.90 
6992/AbsR1 Regulatory protein -1.57 -3.65 
4709/rplP 50S ribosomal protein L16 1.16 2.11 
a parent strain M145 versus ∆abrC3  819 
820 
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TABLE 4. AbrC3 ChIP-chip targets selected by their high enrichment ratio 821 
Regulated 
genea 
Enrichment 
ratiob 
Predicted function of regulated 
gene Time
c 
Predicted binding site 
sequenced 
SCO0167 2.45 Conserved hypothetical protein SCJ1.16c 36 354 GAAGGGGGCG 363 
SCO0951 2.22 Putative transport system permease protein 36 -329 GGTCGCCTTC -318 
SCO1391 5.44 crr ,phosphoenolpyruvate-protein phosphotransferase 48 1113 GAAGGCGGCG 1122 
SCO3020 4.22 Putative integral membrane protein 48 Not found 
SCO3263 2.60 Conserved hypothetical protein 36 -240 GTTCGCCTTC -231 
SCO3334 5.70 trpS, tryptophanyl tRNA synthetase 48 -387 GGCCGCGTTC -378 
SCO3590 2.54 vanR, putative TCS response regulator 36 Not found 
SCO3992 2.45 Hypothetical protein 36 Not found 
SCO4075 6.32 ragA, ABC transport protein, ATP-binding subunit 48 Not found 
SCO4123 5.02 Putative TCS response regulator 48 -674 GAACGCGACC -665 
SCO4596 2.24 abrC3, TCS response regulator 60 -137 CTTCCCGTTC -128 
SCO4630 2.78 Hypothetical protein 36 Not found 
SCO5085 2.23 actII-ORF4, ACT cluster activator protein 36 72 GAAGGCGACC 81 
SCO5236 2.86 nagB, putative glucosamine phosphate isomerase 48 -213 GGTCGCGTTC -204 
SCO5330 3.26 Hypothetical protein SC6G9.03c 36 -975 GAAGGGGGCG -966 
SCO5332 2.21 Hypothetical protein 36 1134 CTTCGCCTTC 1143 
SCO5632 2.36 Hypothetical protein SC6A9.3 36 -1261 GAACGGGACG -1252 
SCO5638 2.76 Integral membrane protein 36 X 
SCO5691 2.24 Putative secreted sugar hydrolase 48 -777 GAACGCGGCG -768 
SCO5729 2.33 Conserved hypothetical protein SC3C3.15c 36 Not found 
SCO5912 4.30 Probable secreted protease 48 -54 CTCCCCCTTC -45 
SCO5966 2.24 Putative oxidase 48 -803 GAAGGCGGAC -794 
SCO6273 2.18 cpkC, putative type I polyketide synthase 48 3138 CGCCCCGTTC 3147 
SCO6732 2.29 Putative fatty acid oxidative multifunctional enzyme 36 1140 GAAGGCGGCC 1149 
SCO6820 2.94 Putative oxidoreductase 48 -519 GAACGCGGCC -510 
SCO6941 2.55 cvnC8, hypothetical protein SC1G8.13c 36 -306 GGCCGCCTTC -297 
SCO6951 2.55 Conserved hypothetical protein 36 -411 CGCCGCGTTC -402 
SCO6992 2.78 absR1, regulatory protein 48 -321 GAAGGGGACG -312 
SCO7077 2.24 Putative integral membrane protein 36 -294 GAAGGCGGCG -285 
SCO7545 2.45 Putative ABC-transport protein, ATP-binding component 48 -369 GGCCGCGTTC -360 
a Putative AbrC3-target genes indicated by the ChIP-chip analysis. 822 
b AbrC3-DNA interaction affinity. 823 
c Time of the ChIP-chip assay at which the shown enrichment ratio has been found. 824 
d Consensus Binding site sequence: 5’-GAASGSGRMS-3’; Numbers indicate the 825 
position of the sequence related to the start codon of the corresponding gene. 826 
The genes that have also shown differential transcription profile are in bold.  827 
828 
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TABLE 5. AbrC3 overlapping targets in ChIP-chip and transcriptome analyses 829 
SCO 
Enrichment 
ratioa Predicted function of regulated gene Time
b 
Predicted binding site 
sequencec 
SCO0736 1.50 Putative secreted protein 36 -53 GAAGGCGACC -44 
SCO2113 1.59 bfr, putative bacterioferritin 48 -26 GTTCCCGTTC -17 
SCO3328 1.48 bdtA, hypothetical protein 48 -46 GAAGGGGAAG -37 
SCO4596 2.24 abrC3, TCS response regulator 60 -137 CTTCCCGTTC -128 
SCO4709 1.89 rplP, 50S ribosomal protein L16 36 Not found 
SCO5085 2.23 actII-ORF4, ACT cluster activator protein 36 72 GAAGGCGACC 81 
SCO6809 1.77 Putative integral membrane transport protein 48 -112 GAAGGCGGAC -103 
SCO6992 2.78 absR1, regulatory protein 48 -321 GAAGGGGACG -312 
a AbrC3-DNA interaction affinity by ChIP-chip 830 
b  Time of the ChIP-chip assay at which the shown enrichment ratio has been found. 831 
c Consensus Binding site sequence: 5’-GAASGSGRMS-3’; Numbers indicate the 832 
position of the sequence related to the start codon of the corresponding gene 833 
The genes in bold are up-regulated. The other genes of the table are down-regulated 834 
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 837 
FIGURE’ LEGENDS 838 
 839 
Figure 1: Phenotypic study of the mutants, complementation and overexpression 840 
A) Production of the antibiotics ACT (72 h), CDA (bioassay against B. subtilis at 48 h), 841 
and RED (48 h), by the parent strain (M145) and the mutants ∆abrC1/2/3 and ∆abrC3 842 
and their morphological differentiation (MD) on NA medium.  843 
B) Complementation of ACT production by integration of plasmid pSETabrC3 in the 844 
mutant strain ∆abrC3 in liquid medium NB (ACT liquid), and ACT (72 h), RED (48 h) 845 
and their morphological differentiation (MD) on solid NA medium. 846 
 847 
Figure 2: Overexpression of AbrC3 in S. coelicolor and S. lividans.  848 
ACT production of S. coelicolor M145 (left) and S. lividans 66 (right) transformed with 849 
low copy number plasmid pHJL401 (control) and its derivative pHJLabrC3 in NB 850 
medium at 5 days. Error bars correspond to three independent experiments. In the 851 
bottom part a photograph of the corresponding supernatants. 852 
 853 
Figure 3: EMSA of AbrC3 protein with ChIP-chip selected promoters 854 
EMSA of the AbrC3 protein with different concentration of the protein; A) actII-855 
ORF4p; B) abrC3p; C) SCO0736p; D) absR1p (SCO6992); E) SCO2113p; F) bdtAp 856 
(SCO3328); G) SCO4709p; H) SCO6809p. S: specific competition control (adding the 857 
corresponding unlabelled specific probe); N: non-specific competitor DNA (100-fold 858 
molar excess of sheared sperm salmon DNA), BSA: protein specific control (4 µM of 859 
BSA protein).  860 
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Figure 4: Identification of a putative AbrC3-binding sequence in different genes 862 
A) Consensus sequence identified with the Regulatory Sequence Analysis Tool 863 
consensus alignment of putative promoters* (up to - 400 bp upstream sequences plus 864 
+100 from the translational start point) of genes identified by ChIP-chip and EMSAs. 865 
B) EMSAs of different fragments of the actII-ORF4 promoter* region with 4 µM 866 
AbrC3 (top panel, a scheme of the amplified fragment location in the promoter*). C) 867 
EMSA of AbrC3 protein with actII-ORF4 fragment 4 promoter* with different 868 
concentration of the protein; S: specific competition control (adding 100-fold molar 869 
excess of unlabelled specific probe); N: non-specific competitor DNA (adding 100-fold 870 
excess of sheared sperm salmon DNA), BSA: specific control-2 (adding 4 µM of BSA 871 
protein). 872 
 873 
Figure 5: Location of regulatory protein binding sites in the actII-ORF4 promoter* 874 
region  875 
Location of the binding sequences described in the literature for the proteins AtrA, 876 
DraR, and AfsQ1 in the actII-ORF4 promoter* and the position of the deduced target 877 
sequence for AbrC3 identified in this work 878 
 879 
Figure 6. Scheme of the AbrC3 regulon of S. coelicolor. 880 
Schematic model of the pleiotropic regulatory role of AbrC3 in primary and secondary 881 
metabolism, morphological differentiation, and the putative gene network governed by 882 
AbrC3. → positive control (green); —♦ negative control (red); —— direct control 883 
(solid line); − − − indirect control (dashed line). (1) data from Wang et al., 2013.  884 






